Forem

Shalu Shrotiya profile picture

Shalu Shrotiya

writes about life sciences, FDA trends, and quality compliance, making complex regulatory topics easier to understand.

Joined Joined on 
What Can QA Teams Learn from Recent FDA Inspections at Rubicon Research (India)?
Cover image for What Can QA Teams Learn from Recent FDA Inspections at Rubicon Research (India)?

What Can QA Teams Learn from Recent FDA Inspections at Rubicon Research (India)?

Comments
9 min read
What Should QA Teams Prepare Before an Unannounced Inspection Occurs?
Cover image for What Should QA Teams Prepare Before an Unannounced Inspection Occurs?

What Should QA Teams Prepare Before an Unannounced Inspection Occurs?

1
Comments 1
8 min read
What Are the Benefits of AI-Based FDA Compliance Tools?
Cover image for What Are the Benefits of AI-Based FDA Compliance Tools?

What Are the Benefits of AI-Based FDA Compliance Tools?

Comments
4 min read
The Leading Alternative to Redica Systems for FDA Compliance in 2025
Cover image for The Leading Alternative to Redica Systems for FDA Compliance in 2025

The Leading Alternative to Redica Systems for FDA Compliance in 2025

Comments
4 min read
Thai T Duong’s Inspection Playbook What Pharma Teams Should Know in 2025
Cover image for Thai T Duong’s Inspection Playbook What Pharma Teams Should Know in 2025

Thai T Duong’s Inspection Playbook What Pharma Teams Should Know in 2025

Comments
5 min read
Is AI the future of FDA audit readiness?
Cover image for Is AI the future of FDA audit readiness?

Is AI the future of FDA audit readiness?

Comments
5 min read
loading...